Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 800 results for "alexion pharmaceuticals"

Commit To Buy Alexion Pharmaceuticals At $145, Earn 11% Using Options

Alexion Pharmaceuticals (ALXN) Trading Near $191.07 Resistance...

With bullish technical indicators and a 4 STARS (out of 5) buy ranking from Standard & PooraEUR(TM)s, Alexion Pharmaceuticals Inc ("ALXN) could be an attractive play for investors according to ..., 4 days ago

16 images for alexion pharmaceuticals

American Banking News, 3 weeks ago
Nasdaq, 1 week ago
One News Page United Kingdom, 2 weeks ago
ETF Channel, 3 weeks ago
Nasdaq, 3 weeks ago
Providence Business News, 1 month ago
Waterbury Republican American, 1 month ago
Jutia Group, 2 months ago
FOX 61, 1 month ago
PharmaceuticalProcessing, 1 month ago

Stock Investors Sell Off Shares of Alexion Pharmaceuticals, Down 2.6%

Down 2.6% to $178.58, Alexion Pharmaceuticals (NASDAQ:ALXN), is one of today's notable movers. The S&P is trading lower by 0.9% to 2,073 and the Dow is trading 1.1% lower
 Individual.com4 days ago Investors Buy Shares of Alexion Pharmaceuticals on Weakness After Insider Selling (ALXN)  SleekMoney1 week ago Traders Sell Shares of Alexion Pharmaceuticals on Strength (ALXN)  SleekMoney1 week ago Traders Sell Alexion Pharmaceuticals on Strength (ALXN)  WKRB News1 week ago

Look for Shares of Alexion Pharmaceuticals to Potentially Pullback after Yesterday's 3.15% Rise

(Comtex SmarTrend(R)) Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $176.76 to a high of $184.75. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high of $181.97 on ...
 Individual.com1 week ago Alexion Pharmaceuticals Falls 1.36% on Heavy Volume: Watch For Potential Rebound  Individual.com2 weeks ago Watch for Alexion Pharmaceuticals to Potentially Rebound After Falling 1.14% Yesterday  Individual.com3 weeks ago

Alexion Pharmaceuticals has Relatively Underperformed its Peers in the Biotechnology Industry (ALXN, MYGN, ALKS, ISIS, INFI)

(Financial News Network On) Below are five companies in the Biotechnology industry that underperformed yesterday on a relative basis. This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible ...
 Individual.com1 month ago Best Relative Performance in the Biotechnology Industry Detected in Shares of AMAG Pharmaceuticals (AMAG, RGEN, ALXN, AMGN, ARWR)  Comtex SmarTrend1 week ago Lowest PEG Ratio in the Biotechnology Industry Detected in Shares of Gilead Sciences (GILD, UTHR, CELG, ALXN, LGND)  Comtex SmarTrend1 week ago Relatively Good Performance Detected in Shares of Orexigen Therapeutics in the Biotechnology Industry (OREX, REGN, ALXN, BMRN, SPPI)  Comtex SmarTrend1 week ago

Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) is getting insufficient credit from investors for its development pipeline, an analyst said Wednesday. The company's sole commercial product, Soliris, is approved for treating two rare blood disorders ...
 Benzinga.com2 weeks ago

Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and Alexion Pharma

/PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Investor-Edge has initiated coverage on the following equities: MannKind Corporation (NASDAQ: MNKD), Novavax Inc. (NASDAQ: NVAX), Curis Inc. (NASDAQ: ...
 TickerTech.com2 weeks ago ALEXION PHARMACEUTICALS : Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and Alexion Pharma  4 Traders2 weeks ago

Possible Bearish Inside Day Candle Pattern Detected for Alexion Pharmaceuticals (NASDAQ:ALXN)

Written on Tue, 02/17/2015 - 4:42pm By Amy Schwartz SmarTrend's candlestick scanner has spotted a possible bearish inside day candle pattern in Alexion Pharmaceuticals ( NASDAQ:ALXN ) based on the price action in the company's shares. Today's ...
 Comtex SmarTrend1 month ago

High R&D Expenditure Will Positively Impact the Global Acquired Orphan Blood Diseases Therapeutics Market through 2019: TechNavio

LONDON--(EON: Enhanced Online News Soliris, manufactured by Alexion Pharmaceuticals, is the only drug available for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) and also carries the title of the most expensive drug in the world ...
 EON: Enhanced Online News2 weeks ago New Market Research Report: Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019  EMoneyDaily4 days ago Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019 Report Share  Wall Street Select1 week ago

ALXN Makes Notable Cross Below Critical Moving Average

In trading on Wednesday, shares of Alexion Pharmaceuticals Inc. (ALXN) crossed below their 200 day moving average of $175.59, changing hands as low as $175.46
 Industrial Info Financials4 days ago

Alexion Deal in Hand, Blueprint Readies IPO Pitch

Three weeks ago, Blueprint Medicines inked its first major pharma partnership. Now it wants to woo public investors, too. The Cambridge, MA-based company filed papers on Monday outlining plans for an initial public offering. Should Blueprint ...
 Xconomy6 days ago Blueprint Medicines, Alexion Pharmaceuticals ink $265M deal  Center Watch3 weeks ago Blueprint Medicines Forms $265M Collaboration With Alexion Pharmaceuticals  Dow Jones Financial Information Services3 weeks ago Blueprint Medicines in up to $265 million deal with Alexion  Pharma Letter3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - alexion pharmaceuticals
Get updated on latest news & your favorite topics right in your inbox!
More     Less